Rubius Therapeutics, Inc. is a biopharmaceutical company engaged in the development of Red Cell Therapeutics utilizing its Rubius Erythrocyte Design Platform. The company’s areas of therapeutic focus include autoimmune diseases, cancer and rare diseases.